New Horizon for Treatment of Inherited Retinal Dystrophy
Latest developments and innovations in ocular gene edit
Pavan Solanki
glaucoma, Oncology, pharma, retinal dystrophy, voretigene
0 Comment
Latest developments and innovations in ocular gene edit
Partner Content/ Partner content/ Press releases
Pavan Solanki
gene editing, gene therapy, glaucoma, ophthalmology, santen
0 Comment
Ophthalmic Drugs Conference London
Piotr Wnuk
Astellas, gene therapy, glaucoma, ocular disorders, ophthalmology, Quethera
0 Comment
Pavan Solanki
glaucoma, NHS, ophthalmic, ophthalmology, retina
0 Comment
Ophthalmic Drugs Conference 2018
Healthcare/ Partner content/ Press releases
Pavan Solanki
glaucoma, lentivector, ophthalmic, preclinical, vision
0 Comment
Europe’s Leading Ophthalmic Conference
Healthcare/ Partner content/ Press releases
Pavan Solanki
drugs, glaucoma, ophthalmic, ophthalmology, technologies
Sessions at Ophthalmic Drugs
Pavan Solanki
glaucoma, nanotechnology, ophthalmology, optical, santen
Ophthalmic Drugs Conference
Digital/ Healthcare/ Partner Content/ Partner content/ Press releases
Pavan Solanki
cataract, glaucoma, nanotechnology, ophthalmic, ophthalmology
0 Comment
Emerging & New Technologies in Drug Development
Digital/ Healthcare/ Partner Content/ Partner content/ Press releases
Pavan Solanki
Diabetic, DME, DMO, glaucoma, nanotechnology
0 Comment